Sanofi–GSK COVID-19 vaccine is found to be effective against the Omicron variant
The Sanofi–GSK COVID-19 vaccine is found to be effective against the Omicron variant.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthSanofi–GSK COVID-19 vaccine is found to be effective against the Omicron variant
View Premium plansBrowse free archive reportsThe Sanofi–GSK COVID-19 vaccine is found to be effective against the Omicron variant.